A Novel End-To-End Feature Selection and Diagnosis Method for Rotating Machinery

por Wang, Gang, Zhao, Yang, Zhang, Jiasi, Ning, Yongjie
Publicado 2021

P807: CLASS Ⅱ FERROPTOSIS INDUCERS ARE A NOVEL THERAPEUTIC APPROACH FOR T(4;14)-POSITIVE MULTIPLE MYELOMA

por Zhang, Jiasi, Liu, Yuxi, Zuo, Liping, Fan, Fengjuan, Yan, Han, Zhao, Fei, Zhang, Bo, Hu, Yu, Sun, Chunyan
Publicado 2023

Efficacy and safety of mesenchymal stem cells co-infusion in allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis

por Li, Teng, Luo, Chengxin, Zhang, Jiasi, Wei, Ling, Sun, Wei, Xie, Qin, Liu, Yan, Zhao, Yongli, Xu, Shuangnian, Wang, Lihua
Publicado 2021

Safety and feasibility assessment of extending the flushing interval in totally implantable venous access port flushing during the non-treatment stage for patients with breast canc...

por Wang, Yinhuan, Tian, Hao, Chen, Xianchun, Zhang, Jiasi, Wang, Li, Fan, Haiyan, Zhang, Yi, Qi, Xiaowei, Hu, Shaoyi, Yang, Ying
Publicado 2022

Increased ICU mortality in septic shock patients with hypo- or hyper- serum osmolarity: A retrospective study

por Heng, Gang, Zhang, Jiasi, Dong, Yi, Jia, Jiankun, Huang, Benqi, Shen, Yanbing, Wang, Dan, Lan, Zhen, Zhang, Jianxin, Fu, Tao, Jin, Weidong
Publicado 2023

Downregulation of XBP1 protects kidney against ischemia-reperfusion injury via suppressing HRD1-mediated NRF2 ubiquitylation

por Zhang, Ji, Zhang, Jiasi, Ni, Haiqiang, Wang, Yanfeng, Katwal, Gaurav, Zhao, Yuanyuan, Sun, Kailun, Wang, Mengqin, Li, Qingwen, Chen, Gen, Miao, Yun, Gong, Nianqiao
Publicado 2021

CD9, a potential leukemia stem cell marker, regulates drug resistance and leukemia development in acute myeloid leukemia

por Liu, Yongliang, Wang, Guiqin, Zhang, Jiasi, Chen, Xue, Xu, Huailong, Heng, Gang, Chen, Jun, Zhao, Yongchun, Li, Jiatao, Ni, Yuanli, Zhang, Yingzi, Shan, Juanjuan, Qian, Cheng
Publicado 2021

XBP1 modulates endoplasmic reticulum and mitochondria crosstalk via regulating NLRP3 in renal ischemia/reperfusion injury

por Ni, Haiqiang, Ou, Zhiyu, Wang, Yuchen, Liu, Yanna, Sun, Kailun, Zhang, Ji, Zhang, Jiasi, Deng, Wenfeng, Zeng, Wenli, Xia, Renfei, Xu, Jian, Gong, Nianqiao, Miao, Yun
Publicado 2023

High-Affinity Chimeric Antigen Receptor With Cross-Reactive scFv to Clinically Relevant EGFR Oncogenic Isoforms

por Thokala, Radhika, Binder, Zev A., Yin, Yibo, Zhang, Logan, Zhang, Jiasi Vicky, Zhang, Daniel Y., Milone, Michael C., Ming, Guo-li, Song, Hongjun, O’Rourke, Donald M.
Publicado 2021